» Articles » PMID: 15781451

Nectin-like Protein 2 Defines a Subset of T-cell Zone Dendritic Cells and is a Ligand for Class-I-restricted T-cell-associated Molecule

Abstract

Dendritic cells (DCs) are a phenotypically and functionally heterogenous population of leukocytes with distinct subsets serving a different set of specialized immune functions. Here we applied an in vitro whole cell panning approach using antibody phage display technology to identify cell-surface epitopes specifically expressed on human blood BDCA3(+) DCs. A single-chain antibody fragment (anti-1F12 scFv) was isolated that recognizes a conserved surface antigen expressed on both human BDCA3(+) DCs and mouse CD8alpha(+) DCs. We demonstrate that anti-1F12 scFv binds Nectin-like protein 2 (Necl2, Tslc1, SynCaM, SgIGSF, or Igsf4), an adhesion molecule involved in tumor suppression, synapse formation, and spermatogenesis. Thus, Necl2 defines a specialized subset of DCs in both mouse and human. We further show that Necl2 binds Class-I-restricted T-cell-associated molecule (CRTAM), a receptor primarily expressed on activated cytotoxic lymphocytes. When present on antigen presenting cells, Necl2 regulates IL-22 expression by activated CD8(+) T-cells. We propose that Necl2/CRTAM molecular pair could regulate a large panel of cell/cell interactions both within and outside of the immune system.

Citing Articles

Identification of NECTIN1 as a novel restriction factor for flavivirus infection.

Qi S, Sun C, Wang J, Wo L, Li Y, Wang C mBio. 2024; 15(12):e0270824.

PMID: 39570015 PMC: 11633101. DOI: 10.1128/mbio.02708-24.


MERTK inhibition selectively activates a DC - T-cell axis to provide anti-leukemia immunity.

Huelse J, Bhasin S, Jacobsen K, Yim J, Thomas B, Branella G Leukemia. 2024; 38(12):2685-2698.

PMID: 39322710 DOI: 10.1038/s41375-024-02408-2.


Molecular interaction of metastasis suppressor genes and tumor microenvironment in breast cancer.

Supuramanian S, Dsa S, Harihar S Explor Target Antitumor Ther. 2023; 4(5):912-932.

PMID: 37970212 PMC: 10645471. DOI: 10.37349/etat.2023.00173.


Progress on Phage Display Technology: Tailoring Antibodies for Cancer Immunotherapy.

Franca R, Studart I, Bezerra M, Pontes L, Barbosa A, Brigido M Viruses. 2023; 15(9).

PMID: 37766309 PMC: 10536222. DOI: 10.3390/v15091903.


ITGAL as a prognostic biomarker correlated with immune infiltrates in melanoma.

Deng T, Wang C, Gao C, Zhang Q, Guo J Front Oncol. 2023; 13:1181537.

PMID: 37388230 PMC: 10300562. DOI: 10.3389/fonc.2023.1181537.